Novavax (NASDAQ:NVAX) stock is up around 3,500% so far this year. And that's after a significant recent decline. Earlier this month, shares of Novavax were up nearly 4,400% year to date.
These jaw-dropping gains might make you wish you had bought shares of Novavax back when the biotech went public. If the stock has skyrocketed so much this year, the returns for investors who got in on the ground floor must be truly staggering, right? Not really. If you invested $1,000 in Novavax's initial public offering (IPO), this is how much money you'd have now.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,